10x Genomics (TXG) is incorporating medical artificial intelligence software company Lunit's AI-powered pathology platform, Lunit SCOPE IO, into its oncology biomarker discovery workflow, Lunit said Thursday.
The platform adds the ability to analyze Hematoxylin and Eosin pathology images alongside spatial molecular data generated from 10x's oncology-focused clinical research studies, according to a statement.
Financial terms of the collaboration were not provided.
Price: $66.27, Change: $-1.02, Percent Change: -1.52%